Servier Suspected Of Misleading European Commission In EU Anti-Trust Probe
This article was originally published in The Pink Sheet Daily
Executive Summary
Specifics of the accusations against the French pharma aren't clear, but it could face a fine amounting to 1 percent of annual sales.